Hangzhou Tigermed Consulting Co., Ltd (HKG: 3347)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
32.35
-1.65 (-4.85%)
Nov 22, 2024, 4:08 PM HKT

Hangzhou Tigermed Consulting Company Description

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally.

It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services.

It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services.

In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services.

Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.

Hangzhou Tigermed Consulting Co., Ltd
Hangzhou Tigermed Consulting logo
Country China
Founded 2004
Industry Diagnostics & Research
Sector Healthcare
Employees 9,701
CEO Xiaochun Cao

Contact Details

Address:
Shengda Science Park
Hangzhou, Zhejiang Province 310051
China
Phone 86 571 2888 7227
Website tigermedgrp.com

Stock Details

Ticker Symbol 3347
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE1000040M1
SIC Code 8731

Key Executives

Name Position
Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D. Co-Founder and Chairman
Dr. Xiaochun Cao M.D. Co-Founder, GM and Executive Director
Hao Wu President and Executive Director
Chengcheng Yang Chief Financial Officer
Zengyu Wen Executive Vice President, Chief Operating Officer and Executive Director
Xiao Ri Li Secretary
Dr. Tianrong Ji M.D., Ph.D. Chief Investment Officer
Guoyun Yu Head of Accounting Department
Jiansong Yang Ph.D. Senior Vice President and Chief Scientific Officer
Alan Liu Chief Compliance Officer